Possible new target for treating one of cancer's deadliest tumors. Researchers have identified an enzyme that may be the weak link in glioblastoma, a brain cancer that is resistant to most treatments
DukeMedicine healthnews, 2013, Vol.19 (9), p.7ISSN: 2153-8387 ;PMID: 24611191
Digital Resources/Online E-Resources